<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Patient Health Record</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">Reason For Referral</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Immunizations</a></li><li><a href="#id6">Social History</a></li><li><a href="#id7">Problems</a></li><li><a href="#id8">Vital Signs</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Encounters</a></li><li><a href="#id11">Medical Equipment</a></li><li><a href="#id12">Assessments</a></li><li><a href="#id13">Plan Of Treatment</a></li><li><a href="#id14">Goals Section</a></li><li><a href="#id15">Health Concerns</a></li><li><a href="#id16">Insurance Providers</a></li><li><a href="#id17">Medications Administered</a></li><li><a href="#id18">Medical (General) History</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">CBC With Differential/Platelet-005009</span><br/>Reviewed date:[REDACTED] 09:13:21 AM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result1_attr1">WBC</td><td>6.8</td><td>3.4-10.8 x10E3/uL</td><td/></tr><tr><td ID="result1_attr2">RBC</td><td>4.71</td><td>4.14-5.80 x10E6/uL</td><td/></tr><tr><td ID="result1_attr3">Hemoglobin</td><td>15.4</td><td>13.0-17.7 g/dL</td><td/></tr><tr><td ID="result1_attr4">Hematocrit</td><td>45.1</td><td>37.5-51.0 %</td><td/></tr><tr><td ID="result1_attr5">MCV</td><td>96</td><td>79-97 fL</td><td/></tr><tr><td ID="result1_attr6">MCH</td><td>32.7</td><td>26.6-33.0 pg</td><td/></tr><tr><td ID="result1_attr7">MCHC</td><td>34.1</td><td>31.5-35.7 g/dL</td><td/></tr><tr><td ID="result1_attr8">RDW</td><td>11.7</td><td>11.6-15.4 %</td><td/></tr><tr><td ID="result1_attr9">Platelets</td><td>193</td><td>150-450 x10E3/uL</td><td/></tr><tr><td ID="result1_attr10">Neutrophils</td><td>49</td><td>Not Estab. %</td><td/></tr><tr><td ID="result1_attr11">Lymphs</td><td>35</td><td>Not Estab. %</td><td/></tr><tr><td ID="result1_attr12">Monocytes</td><td>15</td><td>Not Estab. %</td><td/></tr><tr><td ID="result1_attr13">Eos</td><td>1</td><td>Not Estab. %</td><td/></tr><tr><td ID="result1_attr14">Basos</td><td>0</td><td>Not Estab. %</td><td/></tr><tr><td ID="result1_attr15">Neutrophils (Absolute)</td><td>3.3</td><td>1.4-7.0 x10E3/uL</td><td/></tr><tr><td ID="result1_attr16">Lymphs (Absolute)</td><td>2.3</td><td>0.7-3.1 x10E3/uL</td><td/></tr><tr><td ID="result1_attr17">Monocytes(Absolute)</td><td>1.0</td><td>0.1-0.9 x10E3/uL</td><td/></tr><tr><td ID="result1_attr18">Eos (Absolute)</td><td>0.1</td><td>0.0-0.4 x10E3/uL</td><td/></tr><tr><td ID="result1_attr19">Baso (Absolute)</td><td>0.0</td><td>0.0-0.2 x10E3/uL</td><td/></tr><tr><td ID="result1_attr20">Immature Granulocytes</td><td>0</td><td>Not Estab. %</td><td/></tr><tr><td ID="result1_attr21">Immature Grans (Abs)</td><td>0.0</td><td>0.0-0.1 x10E3/uL</td><td/></tr><tr><td colspan="4"><span class="content_span">Lipid Panel With LDL/HDL Ratio-235010</span><br/>Reviewed date:[REDACTED] 09:13:07 AM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result2_attr1">Cholesterol, Total</td><td>180</td><td>100-199 mg/dL</td><td/></tr><tr><td ID="result2_attr2">Triglycerides</td><td>46</td><td>0-149 mg/dL</td><td/></tr><tr><td ID="result2_attr3">HDL Cholesterol</td><td>62</td><td>&gt;39 mg/dL</td><td/></tr><tr><td ID="result2_attr4">VLDL Cholesterol Cal</td><td>9</td><td>5-40 mg/dL</td><td/></tr><tr><td ID="result2_attr5">LDL Chol Calc (NIH)</td><td>109</td><td>0-99 mg/dL</td><td/></tr><tr><td ID="result2_attr6">LDL/HDL Ratio</td><td>1.8</td><td>0.0-3.6 ratio</td><td ID="result2_attr6_notes"><p>                                              2X Avg.Risk  6.2    5.0</p><p>                                             1/2 Avg.Risk  1.0    1.5</p><p>                                              3X Avg.Risk  8.0    6.1</p><p>                                                 Avg.Risk  3.6    3.2</p><p>                                                           Men  Women</p><p>                                                   LDL/HDL Ratio</p></td></tr><tr><td colspan="4"><span class="content_span">CMP14+eGFR-334943</span><br/>Reviewed date:[REDACTED] 09:13:14 AM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result3_attr1">Glucose</td><td>87</td><td>70-99 mg/dL</td><td/></tr><tr><td ID="result3_attr2">BUN</td><td>13</td><td>8-27 mg/dL</td><td/></tr><tr><td ID="result3_attr3">Creatinine</td><td>1.26</td><td>0.76-1.27 mg/dL</td><td/></tr><tr><td ID="result3_attr4">eGFR</td><td>60</td><td>&gt;59 mL/min/1.73</td><td/></tr><tr><td ID="result3_attr5">BUN/Creatinine Ratio</td><td>10</td><td>10-24</td><td/></tr><tr><td ID="result3_attr6">Sodium</td><td>143</td><td>134-144 mmol/L</td><td/></tr><tr><td ID="result3_attr7">Potassium</td><td>4.1</td><td>3.5-5.2 mmol/L</td><td/></tr><tr><td ID="result3_attr8">Chloride</td><td>106</td><td>96-106 mmol/L</td><td/></tr><tr><td ID="result3_attr9">Carbon Dioxide, Total</td><td>22</td><td>20-29 mmol/L</td><td/></tr><tr><td ID="result3_attr10">Calcium</td><td>9.2</td><td>8.6-10.2 mg/dL</td><td/></tr><tr><td ID="result3_attr11">Protein, Total</td><td>6.2</td><td>6.0-8.5 g/dL</td><td/></tr><tr><td ID="result3_attr12">Albumin</td><td>4.0</td><td>3.8-4.8 g/dL</td><td/></tr><tr><td ID="result3_attr13">Globulin, Total</td><td>2.2</td><td>1.5-4.5 g/dL</td><td/></tr><tr><td ID="result3_attr14">A/G Ratio</td><td>1.8</td><td>1.2-2.2</td><td/></tr><tr><td ID="result3_attr15">Bilirubin, Total</td><td>0.6</td><td>0.0-1.2 mg/dL</td><td/></tr><tr><td ID="result3_attr16">Alkaline Phosphatase</td><td>65</td><td>44-121 IU/L</td><td/></tr><tr><td ID="result3_attr17">AST (SGOT)</td><td>11</td><td>0-40 IU/L</td><td/></tr><tr><td ID="result3_attr18">ALT (SGPT)</td><td>13</td><td>0-44 IU/L</td><td/></tr><tr><td colspan="4"><span class="content_span">Occult Blood, Fecal, IA-182949</span><br/>Reviewed date:[REDACTED] 01:13:51 PM<br/>Interpretation:<br/>Performing Lab:Labcorp [REDACTED], [REDACTED][REDACTED] Phone - [REDACTED], Director - MDFarrier<br/>Notes/Report:</td></tr><tr><td ID="result4_attr1">Occult Blood, Fecal, IA</td><td>Negative</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id3" href="#toc">Reason For Referral</a></h3><div><table width="100%" border="1"><tbody><tr><th>Reason</th><td>F/u with testing </td></tr><tr><th>Diagnosis 1</th><td>Disorder of kidney and ureter, unspecified (N28.9)</td></tr><tr><th>Referral Organization</th><td>MCM [REDACTED] N</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Urology</td></tr><tr><th>Procedure 1</th><td>URINALYSIS, AUTO, W/O SCOPE (81003)</td></tr><tr><th>Procedure 2</th><td>US EAM ABDO BACK WALL, LIM (76775)</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 12:33:55 PM &gt;faxed</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>F/U with Testing [REDACTED] **Please send back to [REDACTED] **</td></tr><tr><th>Diagnosis 1</th><td>Disorder of kidney and ureter, unspecified (N28.9)</td></tr><tr><th>Referral Organization</th><td>MCM [REDACTED]</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>Advanced Urology Institute, Inc</td></tr><tr><th>Referred Provider Specialty</th><td>Urology</td></tr><tr><th>Procedure 1</th><td>URINALYSIS, AUTO, W/O SCOPE (81003)</td></tr><tr><th>Procedure 2</th><td>US EAM ABDO BACK WALL, LIM (76775)</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 10:17:22 AM &gt;please review appt [REDACTED], [REDACTED] [REDACTED] 12:16:33 PM &gt;faxed</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table><table width="100%" border="1"><tbody><tr><th>Reason</th><td>F/u with Testing</td></tr><tr><th>Diagnosis 1</th><td>Malignant neoplasm of prostate (C61)</td></tr><tr><th>Referral Organization</th><td>MCM St. Petersburg 38th Ave N</td></tr><tr><th>Referring Provider First Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Last Name</th><td>[REDACTED]</td></tr><tr><th>Referring Provider Speciality</th><td>Internal Medicine</td></tr><tr><th>Referred Provider</th><td>[REDACTED]</td></tr><tr><th>Referred Provider Specialty</th><td>Urology</td></tr><tr><th>Procedure 1</th><td>URINALYSIS, AUTO, W/O SCOPE (81003)</td></tr><tr><th>General Notes</th><td>[REDACTED] [REDACTED] 02:18:09 PM &gt;faxed</td></tr><tr><th>Referral Priority</th><td>Routine</td></tr><tr><th>Referral Appointment Date</th><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">NIFEdipine ER 90 MG</td><td ID="instruction1">1 tablet on an empty stomach Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Lisinopril 40 MG</td><td ID="instruction2">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">hydrALAZINE HCl 50 MG</td><td ID="instruction3">1 tablet with food Orally Three times a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Metoprolol Succinate 50 MG</td><td ID="instruction4">1 capsule Orally Once a day for 90 days</td><td ID="medication4notes">*please review for potential update for e-prescription and drug interaction check* *Reorder from Medispan for eRx and Interaction Alerts*</td><td/><td/><td>Active</td></tr><tr><td ID="medication5">Lisinopril 40 MG</td><td ID="instruction5">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Immunizations</a></h3><div><table width="100%" border="1"><thead><tr><th>Vaccine</th><th>Route</th><th>Administration Date</th><th>Status</th><th>Comments</th></tr></thead><tbody><tr><td ID="immunization1">Influenza (whole)</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization1notes">  Immunization Given by from source eCW:: </td></tr><tr><td ID="immunization2">Pneumococcal conjugate PCV 13</td><td>Unknown</td><td>[REDACTED]</td><td>Administered</td><td ID="immunization2notes">  Immunization Given by from source eCW:: </td></tr></tbody></table></div><h3><a name="id6" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>nonsmoker</td><td/></tr></tbody></table><span class="content_span">Alcohol Screen (Audit-C)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id7" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>Malignant tumor of prostate (399068003)</td><td ID="Problem1">Malignant neoplasm of prostate (C61)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>94350006</td><td ID="Problem2">Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes (C77.5)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>94222008</td><td ID="Problem3">Secondary malignant neoplasm of bone (C79.51)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Hydronephrosis with renal and ureteral calculous obstruction (197788000)</td><td ID="Problem4">Hydronephrosis with renal and ureteral calculous obstruction (N13.2)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Cystic disease of liver (72925005)</td><td ID="Problem5">Cystic disease of liver (Q44.6)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>History of polyp of colon (situation) (428283002)</td><td ID="Problem6">Personal history of colonic polyps (Z86.010)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>Essential hypertension (59621000)</td><td ID="Problem7">Essential (primary) hypertension (I10)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>267432004</td><td ID="Problem8">Pure hypercholesterolemia, unspecified (E78.00)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Heart Rate</th><td>86 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital2">Temperature</th><td>97.5 degrees Fahrenheit</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital3">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital4">Blood pressure diastolic</th><td>77 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital5">Oximetry</th><td>97 %</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital6">Weight-kg</th><td>86.18 kg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital7">Height</th><td>67 in</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital8">Blood pressure systolic</th><td>153 mm Hg</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital9">Weight</th><td>190 lbs</td><td>[REDACTED]</td><td/></tr><tr><th ID="vital10">BMI</th><td>29.75 kg/m2</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Procedures</a></h3><div><table width="100%" border="1"><thead><tr><th>Procedure</th><th>Date Ordered</th><th>Date Performed</th><th>Result</th><th>Body Site</th></tr></thead><tbody><tr><td ID="procedure1">VENIPUNCT, ROUTINE*</td><td>[REDACTED]</td><td/><td>N/A</td><td/></tr></tbody></table></div><h3><a name="id10" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM [REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>[REDACTED] N</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>[REDACTED] N</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Essential (primary) hypertension I10</td></tr><tr><td>MCM [REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Encounter for screening for malignant neoplasm of colon Z12.11</td></tr><tr><td>MCM [REDACTED] [REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Essential (primary) hypertension I10</td></tr><tr><td>MCM [REDACTED] N</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Essential (primary) hypertension I10</td></tr><tr><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Essential (primary) hypertension I10</td></tr><tr><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td/></tr><tr><td>MCM St. Petersburg [REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Vitamin B12 deficiency E53.8</td></tr><tr><td>MCM [REDACTED] N</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Malignant neoplasm of prostate C61 ; Essential (primary) hypertension I10 ; Hydronephrosis with renal and ureteral calculous obstruction N13.2 and Pure hypercholesterolemia, unspecified E78.00</td></tr><tr><td>MCM [REDACTED] [REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Malignant neoplasm of prostate C61 ; Secondary malignant neoplasm of bone C79.51 ; Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes C77.5 ; Essential (primary) hypertension I10 ; Hydronephrosis with renal and ureteral calculous obstruction N13.2 ; Personal history of colonic polyps Z86.010 ; Cystic disease of liver Q44.6 ; Benign lipomatous neoplasm of other sites D17.79 ; Pure hypercholesterolemia, unspecified E78.00 ; Non-functioning kidney N28.9 ; BMI 29.0-29.9,adult Z68.29 and Annual physical exam Z00.00</td></tr><tr><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Malignant neoplasm of prostate C61 ; Secondary malignant neoplasm of bone C79.51 ; Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes C77.5 ; Essential (primary) hypertension I10 ; Hydronephrosis with renal and ureteral calculous obstruction N13.2 ; Personal history of colonic polyps Z86.010 ; Cystic disease of liver Q44.6 ; Benign lipomatous neoplasm of other sites D17.79 ; Pure hypercholesterolemia, unspecified E78.00 ; Non-functioning kidney N28.9 and BMI 29.0-29.9,adult Z68.29</td></tr><tr><td>MCM [REDACTED] N</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Malignant neoplasm of prostate C61 ; Secondary malignant neoplasm of bone C79.51 ; Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes C77.5 ; Essential (primary) hypertension I10 ; Hydronephrosis with renal and ureteral calculous obstruction N13.2 ; Personal history of colonic polyps Z86.010 ; Cystic disease of liver Q44.6 ; Benign lipomatous neoplasm of other sites D17.79 ; Pure hypercholesterolemia, unspecified E78.00 ; Non-functioning kidney N28.9 and BMI 28.0-28.9,adult Z68.28</td></tr></tbody></table></div><h3><a name="id11" href="#toc">Medical Equipment</a></h3><div>No Information</div><h3><a name="id12" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Malignant neoplasm of prostate (ICD-10 - C61)</td><td/><td/><td>currently observation treatment.urologist checks PSA every 6 months</td></tr><tr><td ID="ref2">[REDACTED]</td><td>Malignant neoplasm of prostate (ICD-10 - C61)</td><td/><td/><td>currently observation treatment.urologist checks PSA every 6 months</td></tr><tr><td ID="ref3">[REDACTED]</td><td>Malignant neoplasm of prostate (ICD-10 - C61)</td><td/><td/><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>Encounter for screening for malignant neoplasm of colon (ICD-10 - Z12.11)</td><td/><td/><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Malignant neoplasm of prostate (ICD-10 - C61)</td><td/><td/><td>currently observation treatment.urologist checks PSA every 6 months</td></tr><tr><td ID="ref7">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Vitamin B12 deficiency (ICD-10 - E53.8)</td><td/><td/><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Secondary malignant neoplasm of bone (ICD-10 - C79.51)</td><td/><td/><td>observation with urology follow-up</td></tr><tr><td ID="ref13">[REDACTED]</td><td>Secondary malignant neoplasm of bone (ICD-10 - C79.51)</td><td/><td/><td>observation with urology follow-up</td></tr><tr><td ID="ref14">[REDACTED]</td><td>Secondary malignant neoplasm of bone (ICD-10 - C79.51)</td><td/><td/><td>observation with urology follow-up</td></tr><tr><td ID="ref15">[REDACTED]</td><td>Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes (ICD-10 - C77.5)</td><td/><td/><td>observation</td></tr><tr><td ID="ref16">[REDACTED]</td><td>Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes (ICD-10 - C77.5)</td><td/><td/><td>observation</td></tr><tr><td ID="ref17">[REDACTED]</td><td>Secondary and unspecified malignant neoplasm of intrapelvic lymph nodes (ICD-10 - C77.5)</td><td/><td/><td>observation</td></tr><tr><td ID="ref18">[REDACTED]</td><td>Hydronephrosis with renal and ureteral calculous obstruction (ICD-10 - N13.2)</td><td/><td/><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>Hydronephrosis with renal and ureteral calculous obstruction (ICD-10 - N13.2)</td><td/><td/><td>stable ccontinue to observe</td></tr><tr><td ID="ref20">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>Hydronephrosis with renal and ureteral calculous obstruction (ICD-10 - N13.2)</td><td/><td/><td>stable ccontinue to observe</td></tr><tr><td ID="ref23">[REDACTED]</td><td>Pure hypercholesterolemia, unspecified (ICD-10 - E78.00)</td><td/><td/><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Essential (primary) hypertension (ICD-10 - I10)</td><td/><td/><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Hydronephrosis with renal and ureteral calculous obstruction (ICD-10 - N13.2)</td><td/><td/><td>stable ccontinue to observe</td></tr><tr><td ID="ref26">[REDACTED]</td><td>Personal history of colonic polyps (ICD-10 - Z86.010)</td><td/><td/><td>repeat colonoscopy 5 years from the last  5/2026</td></tr><tr><td ID="ref27">[REDACTED]</td><td>Personal history of colonic polyps (ICD-10 - Z86.010)</td><td/><td/><td>repeat colonoscopy 5 years from the last  5/2026</td></tr><tr><td ID="ref28">[REDACTED]</td><td>Cystic disease of liver (ICD-10 - Q44.6)</td><td/><td/><td>continue to observe</td></tr><tr><td ID="ref29">[REDACTED]</td><td>Cystic disease of liver (ICD-10 - Q44.6)</td><td/><td/><td>continue to observe</td></tr><tr><td ID="ref30">[REDACTED]</td><td>Personal history of colonic polyps (ICD-10 - Z86.010)</td><td/><td/><td>repeat colonoscopy 5 years from the last  5/2026</td></tr><tr><td ID="ref31">[REDACTED]</td><td>Cystic disease of liver (ICD-10 - Q44.6)</td><td/><td/><td>continue to observe</td></tr><tr><td ID="ref32">[REDACTED]</td><td>Benign lipomatous neoplasm of other sites (ICD-10 - D17.79)</td><td/><td/><td>continue to observe</td></tr><tr><td ID="ref33">[REDACTED]</td><td>Benign lipomatous neoplasm of other sites (ICD-10 - D17.79)</td><td/><td/><td>continue to observe</td></tr><tr><td ID="ref34">[REDACTED]</td><td>Pure hypercholesterolemia, unspecified (ICD-10 - E78.00)</td><td/><td/><td>continue observation</td></tr><tr><td ID="ref35">[REDACTED]</td><td>Pure hypercholesterolemia, unspecified (ICD-10 - E78.00)</td><td/><td/><td>continue observation</td></tr><tr><td ID="ref36">[REDACTED]</td><td>Benign lipomatous neoplasm of other sites (ICD-10 - D17.79)</td><td/><td/><td>continue to observe</td></tr><tr><td ID="ref37">[REDACTED]</td><td>Pure hypercholesterolemia, unspecified (ICD-10 - E78.00)</td><td/><td/><td>continue observation</td></tr><tr><td ID="ref38">[REDACTED]</td><td>Non-functioning kidney (ICD-10 - N28.9)</td><td>urology note</td><td/><td>conservative treatment</td></tr><tr><td ID="ref39">[REDACTED]</td><td>Non-functioning kidney (ICD-10 - N28.9)</td><td>urology note</td><td/><td>conservative treatment</td></tr><tr><td ID="ref40">[REDACTED]</td><td>BMI 29.0-29.9,adult (ICD-10 - Z68.29)</td><td/><td>Proper diet and exercise to maintain normal BMI</td><td/></tr><tr><td ID="ref41">[REDACTED]</td><td>BMI 28.0-28.9,adult (ICD-10 - Z68.28)</td><td/><td>Proper diet and exercise to maintain normal BMI</td><td/></tr><tr><td ID="ref42">[REDACTED]</td><td>Non-functioning kidney (ICD-10 - N28.9)</td><td>urology note</td><td/><td>conservative treatment</td></tr><tr><td ID="ref43">[REDACTED]</td><td>BMI 29.0-29.9,adult (ICD-10 - Z68.29)</td><td/><td>Proper diet and exercise to maintain normal BMI</td><td/></tr><tr><td ID="ref44">[REDACTED]</td><td>Annual physical exam (ICD-10 - Z00.00)</td><td/><td>Continue annual physical</td><td/></tr></tbody></table></div><h3><a name="id13" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Pending Test</span><table width="100%" border="1"><thead><tr><th>Test Name</th><th>Order Date</th></tr></thead><tbody><tr><td ID="pendingTest1">VENIPUNCT, ROUTINE*</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest2">VENIPUNCT, ROUTINE*</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest3">Ultrasound : Doppler : Veins Leg Bil. (93970)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest4">Hemoglobin A1c-001453</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest5">CBC With Differential/Platelet-005009</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest6">CBC With Differential/Platelet-005009</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest7">Albumin/Creatinine Ratio,Urine-140285</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest8">Lipid Panel With LDL/HDL Ratio-235010</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest9">Lipid Panel With LDL/HDL Ratio-235010</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest10">PSA (Serial Monitor)-480145</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest11">CMP14+eGFR-334943</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest12">CMP14+eGFR-334943</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest13">CMP14+eGFR-334943</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest14">LIPID PANEL WITH REFLEX TO DIRECT LDL (14852)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest15">MICROALBUMIN, RANDOM URINE W/CREATININE (6517)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest16">MICROALBUMIN, RANDOM URINE W/CREATININE (6517)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest17">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest18">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest19">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest20">CBC (H/H, RBC, INDICES, WBC, PLT) (1759)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest21">CBC (H/H, RBC, INDICES, WBC, PLT) (1759)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest22">HEMOGLOBIN A1c (496)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest23">LIPID PANEL WITH REFLEX TO DIRECT LDL (14852)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest24">MICROALBUMIN, RANDOM URINE W/CREATININE (6517)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest25">MICROALBUMIN, RANDOM URINE W/CREATININE (6517)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest26">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest27">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest28">COMPREHENSIVE METABOLIC PANEL (10231)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest29">CBC (H/H, RBC, INDICES, WBC, PLT) (1759)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest30">CBC (H/H, RBC, INDICES, WBC, PLT) (1759)</td><td>[REDACTED]</td></tr><tr><td ID="pendingTest31">HEMOGLOBIN A1c (496)</td><td>[REDACTED]</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 03:15:00 PM, [REDACTED][REDACTED], [REDACTED]</td></tr></tbody></table></div><h3><a name="id14" href="#toc">Goals Section</a></h3><div>No Information</div><h3><a name="id15" href="#toc">Health Concerns</a></h3><div>No Information</div><h3><a name="id16" href="#toc">Insurance Providers</a></h3><div><table width="100%" border="1"><thead><tr><th>Payer Name</th><th>Payer Address</th><th>Payer Phone</th><th>Subscriber Number</th><th>Group Number</th><th>Insured Name</th><th>Patient Relationship to Insured</th><th>Coverage Start Date</th><th>Coverage End Date</th></tr></thead><tbody><tr><td>Humana Gold Plus Tampa Cap</td><td>PO BOX [REDACTED]</td><td>[REDACTED]</td><td>H75010709</td><td>Y0724001</td><td>[REDACTED]</td><td>Self - patient is the insured</td><td>[REDACTED]</td><td/></tr></tbody></table></div><h3><a name="id17" href="#toc">Medications Administered</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>Instructions</th><th>Date of Administration</th><th>Dosage</th><th>Notes</th></tr></thead><tbody><tr><td ID="therapeuticinjection1">Cyanocobalamin</td><td/><td>[REDACTED]</td><td>1 mL</td><td ID="therapeuticinjection1notes">Hoxhalli, Danjela [REDACTED] 01:18:04 PM EDT &gt;Pt handled well NDC [REDACTED]</td></tr></tbody></table></div><h3><a name="id18" href="#toc">Medical (General) History</a></h3><div><span class="content_span">Medical History</span><table width="100%" border="1"><thead><tr><th>History</th><th>ICD Code</th></tr></thead><tbody><tr><td>hypertension</td><td/></tr><tr><td>prostate cancer status post prostatectomy</td><td/></tr></tbody></table><span class="content_span">Surgical History</span><table width="100%" border="1"><thead><tr><th>Surgery</th><th>Date(Month/Year)</th></tr></thead><tbody><tr><td>prostatectomy for prostate cancer</td><td/></tr></tbody></table></div><br/><br/>
</body></html>